arrow
C

Christopher A. Miller

washington university (wustl)
H指数:96
被引数:7.9万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Evaluation of long-read genome sequencing for genomic profiling of myeloid cancers

长读长基因组测序在髓系肿瘤基因组分析中的应用评估

2025-09-260
PRE
Early Intervention in Patients With Asymptomatic Severe Aortic Stenosis and Myocardial Fibrosis:The EVOLVED Randomized Clinical Trial
2025-01-211
PRE
Recurrent Amplification of Chromosome 7 in Murine AML with Dnmt3aR878H and Npm1cA Mutations Identifies Gab2 As a Possible Therapeutic Target in AML

携带Dnmt3aR878H和Npm1cA突变的鼠类急性髓系白血病中染色体7的反复扩增,将Gab2确定为急性髓系白血病中可能的潜在治疗靶点。

BLOOD
IF23.1
2024-11-050
PRE
Considerations for drug trials in hypertrophic cardiomyopathy
2024-10-270
OAAI
Monitoring clonal burden as an alternative to blast count for myelodysplastic neoplasm treatment response
LEUKEMIA
IF13.4
2024-10-040
PRE
PML::RARA and GATA2 proteins interact via DNA templates to induce aberrant self- renewal in mouse and human hematopoietic cells

PML::RARA和GATA2蛋白通过DNA模板相互作用,诱导小鼠和人类造血细胞的异常自我更新

2024-04-220
OAAI
Remote myocardial fibrosis predicts adverse outcome in patients with myocardial infarction on clinical cardiovascular magnetic resonance imaging
2024-01-010
OAAI
Genomic landscape of TP53-mutated myeloid malignancies
2023-08-1113
OAAI
Genetic characterization of primary and metastatic high-grade serous ovarian cancer tumors reveals distinct features associated with survival
2023-07-0315
OAAI
Computational prediction of MHC anchor locations guides neoantigen identification and prioritization
2023-04-1412
OA
Discovery of a novel genomic alteration that renders leukemic cells resistant to CD19-targeted immunotherapies
2022-10-182
OAAI